Stay updated on Risankizumab in Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab in Psoriatic Arthritis Clinical Trial page.

Latest updates to the Risankizumab in Psoriatic Arthritis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0; no visible changes to the study details or page features.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check26 days agoChange DetectedRevision: v3.4.3 is now shown on the page, replacing the previous v3.4.2 label.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision: v3.4.2 was added. The government funding notice and Revision: v3.4.1 were removed.SummaryDifference0.2%

- Check62 days agoChange DetectedA government funding status notice was added and a new 2025 publication citation (KEEPSAKE 2) was added to Publications, while the older online-ahead-of-print citation was removed and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check69 days agoChange DetectedThe page adds a glossary display option and metadata fields such as Last Update Submitted that Met QC Criteria and Last Update Posted, and updates the No FEAR Act Data label and the revision to v3.4.0.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Risankizumab in Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab in Psoriatic Arthritis Clinical Trial page.